The Four-Year Course of Major Depressive Disorder: The Role of Staging and Risk Factor Determination
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background: Much is still unclear about the mechanisms underlying the course of major depressive disorder (MDD). This study aimed to identify risk factors that predict a poor prognosis of MDD while taking into consideration its chronicity at baseline. Methods: In patients with MDD (n = 767), we examined whether baseline clinical factors, sociodemographics, childhood trauma, personality and life events predicted the 4-year course (i.e. sustained recovery, temporary recovery and chronic course) of MDD. Baseline chronicity of MDD was taken into account by testing whether associations were different for patients with nonchronic versus chronic MDD at baseline. Results: In patients with nonchronic MDD at baseline, 27.8% developed a chronic disorder during follow-up, whereas 53.0% of patients with chronic MDD at baseline had a persistent chronic disorder during follow-up. Severity of MDD, childhood trauma and greater age were important general risk factors for a poor prognosis, independent of MDD chronicity at baseline. In contrast, low extraversion was only important for the course of nonchronic MDD at baseline, while higher education and negative life events (in patients with high neuroticism) were only relevant for the course of chronic MDD at baseline. Conclusions: One out of 4 patients with nonchronic MDD progressed to a chronic disorder, while half of the patients with chronic MDD remained chronic during follow-up. Since several risk factors for a poor prognosis differed for patients with nonchronic and chronic MDD at baseline, treatment targets should be adjusted for current chronicity of MDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
KESSLER, R. C., ANDREWS, G., COLPE, L. J., HIRIPI, E., MROCZEK, D. K., NORMAND, S.-L. T., WALTERS, E. E., & ZASLAVSKY, A. M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006074 · Cited by 10,327
(2001) · Cited by 5,455
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Domains and Facets: Hierarchical Personality Assessment Using the Revised NEO Personality Inventory
Costa Jr., P. T., & McCrae, R. R. (1995) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6401_2 · Cited by 2,077
Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1097 · Cited by 1,645
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
Brugha, T., Bebbington, P., Tennant, C., & Hurry, J. (1985) · Psychological Medicine · doi:10.1017/s003329170002105x · Cited by 1,107
The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods
Penninx, B. W. J. H., Beekman, A. T. F., Smit, J. H., Zitman, F. G., Nolen, W. A., Spinhoven, P., Cuijpers, P., De Jong, P. J., Van Marwijk, H. W. J., Assendelft, W. J. J., et al. (2008) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.256 · Cited by 927
Self-citation
Cited by
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Self-citationComparing network structures on three aspects: A permutation test.
van Borkulo, C. D., van Bork, R., Boschloo, L., Kossakowski, J. J., Tio, P., Schoevers, R. A., Borsboom, D., & Waldorp, L. J. (2023) · Psychological Methods · doi:10.1037/met0000476 · Cited by 1,465
“…shown that, although the prevalence of major depression is higher among women compared to men (Kessler, 2003; Nolen-Hoeksema, 1987), men and women with a depression do not differ in several clinical features (e.g., severity or prospective course; Boschloo et al., 2012, 2014; Schuch et al., 2014).”
BackgroundSelf-citationAssociation of Symptom Network Structure With the Course of Depression
van Borkulo, C., Boschloo, L., Borsboom, D., Penninx, B. W. J. H., Waldorp, L. J., & Schoevers, R. A. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2079 · Cited by 846
Self-citationConstructs of depression and distress in diabetes: time for an appraisal
Snoek, F. J., Bremmer, M. A., & Hermanns, N. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00135-7 · Cited by 449
ter Meulen, W. G., Draisma, S., van Hemert, A. M., Schoevers, R. A., Kupka, R. W., Beekman, A. T. F., & Penninx, B. W. J. H. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.02.004 · Cited by 170
Self-citationTranscranial alternating current stimulation for treating depression: a randomized controlled trial
Wang, H., Wang, K., Xue, Q., Mao, P., Yin, L., Gu, X., Leng, H., Lü, J., Liu, H., Wang, D., et al. (2021) · Brain · doi:10.1093/brain/awab252 · Cited by 143
Malhi, G. S., Bell, E., Singh, A., Bassett, D. L., Berk, M., Boyce, P. M., Bryant, R. A., Gitlin, M. J., Hamilton, A., Hazell, P., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.13035 · Cited by 131
ten Have, M., de Graaf, R., van Dorsselaer, S., Tuithof, M., Kleinjan, M., & Penninx, B. W. J. H. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12874 · Cited by 106
“We know of only two clinical studies, both based on data from NESDA that assessed predictors of chronicity (12, 29).”
BackgroundResultSelf-citationSecondary depression in severe anxiety disorders: a population-based cohort study in Denmark
Meier, S. M., Petersen, L., Mattheisen, M., Mors, O., Mortensen, P. B., & Laursen, T. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00092-9 · Cited by 98
Feng, K., Shen, C., Ma, X., Chen, G., Zhang, M.-L., Xu, B., Liu, X., Sun, J., Zhang, X., Liu, P., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.015 · Cited by 76
Behavioral Toxicity Revisited: Iatrogenic Comorbidity in Psychiatric Evaluation and Treatment
Fava, G. A., Cosci, F., Offidani, E., & Guidi, J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000570 · Cited by 55
“Such role is influenced by the clinical stage of development of a disorder.(27,28) Indeed, DiMascio and Shader(1) noted that a drug effect such as sedation or motor stimulation may be considered adverse for one patient and yet therapeutic and desired for another patient; within the same patient, it may be of value at…”
BackgroundYang, C., Tiemessen, K. M., Bosker, F. J., Wardenaar, K. J., Lie, J., & Schoevers, R. A. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.05.008 · Cited by 51
“39) for MDD [3] and even poor using the DSM-IV criteria [4].”
BackgroundMethodSelf-citationSex similarities and differences in risk factors for recurrence of major depression
van Loo, H. M., Aggen, S. H., Gardner, C. O., & Kendler, K. S. (2018) · Psychological Medicine · doi:10.1017/s0033291717003178 · Cited by 45
“Stratification of subjects based on number of lifetime episodes might lead to more accurate prediction models if risk factors have differential impact on course of illness in patients with a first episode than in patients with an extensive depression history (Kessing et al. 1998; Kendler et al. 2000; Boschloo et al. 2…”
BackgroundMultiple risk factors predict recurrence of major depressive disorder in women
van Loo, H. M., Aggen, S. H., Gardner, C. O., & Kendler, K. S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.045 · Cited by 45
“Analyzing these subgroups might lead to more accurate prediction models if risk factors are different for patients with a first episode than for patients with an extensive depression history (Boschloo et al., 2014; Kendler et al., 2000b).”
Schutter, N., Koorevaar, L., Holwerda, T. J., Stek, M. L., Dekker, J., & Comijs, H. C. (2019) · International Psychogeriatrics · doi:10.1017/s1041610219000231 · Cited by 55
“These ‘Big Five’ personality factors have been found to be associated with human functioning in general, well-being and mental health and more specifically, late-life depression (Boschloo et al. 2014; Duberstein et al. 2008; Koorevaar et al. 2017; McCrae and Costa 2013; Steunenberg et al. 2006; Steunenberg et al. 2007…”
BackgroundJahan-Mihan, A., Stevens, P., Medero-Alfonso, S., Brace, G., Overby, L. K., Berg, K., & Labyak, C. A. (2024) · Nutrients · doi:10.3390/nu16121902 · Cited by 50
“Although more than half of those affected by a Major Depressive Disorder (MDD) recover within six months, and two-thirds to three-quarters of those recover within a year, up to 27% of patients do not recover and develop a recurring depression [4,23].”
BackgroundDing, Y., Wei, Z., Yan, H., & Guo, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.732157 · Cited by 34
“Nearly 30% of individuals with MDD always have symptoms present and develop a chronic condition that is reliant on the illness stage and other risk factors such as childhood trauma and personality (Angst et al., 2009; Boschloo et al., 2014).”
BackgroundStruijs, S. Y., Lamers, F., Spinhoven, P., van der Does, W. A. J., & Penninx, B. W. J. H. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.017 · Cited by 44
Self-citationYang, C., Bosker, F. J., Li, J., & Schoevers, R. A. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1845-1 · Cited by 34
Self-citationFan, C., Li, Y., Lan, T., Wang, W., Mao, X., & Yu, S. Y. (2021) · Food & Function · doi:10.1039/d1fo02676c · Cited by 30
Nonremission and time to remission among remitters in major depressive disorder: Revisiting STAR*D
Mojtabai, R. (2017) · Depression and Anxiety · doi:10.1002/da.22677 · Cited by 29
“Duration of illness, unemployment, and educational attainment are likely indicators of long-term impact of persistent depression on educational and employment outcomes (Boschloo et al., 2014; Luo, Cowell, Musuda, Novak, & Johnson, 2010; Mojtabai, Stuart, Hwang, Eaton, et al., 2015; Mojtabai, Stuart, Hwang, Susukida, e…”
BackgroundStaging of unipolar depression: systematic review and discussion of clinical implications
Cosci, F., & Fava, G. A. (2022) · Psychological Medicine · doi:10.1017/s0033291722001507 · Cited by 28
“More recent elaborations were more geared to recovery, persistence of symptoms, chronicity (Boschloo et al., 2014; Wardenaar, Monden, Conradi, & de Jonge, 2015); or to symptom decline, persistence of symptoms and residual manifestations, course trajectory of increasing symptomatology (Verhoeven,…”
BackgroundThe roles of extracellular vesicles in major depressive disorder
Li, Y., Gui, Y., Zhao, M., Chen, X., Li, H., Chen, T., Zhao, H., Jiang, C., Xu, P., Zhang, S., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1138110 · Cited by 36
“8% of MDD patients did not recover and developed chronic depression (5).”
BackgroundNeuroticism and chronicity as predictors of 9-year course of individual depressive symptoms
van Eeden, W. A., van Hemert, A. M., Carlier, I. V. E., Penninx, B. W. J. H., Spinhoven, P., & Giltay, E. J. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.052 · Cited by 26
Self-citationXiao, Y.-G., Wu, H.-B., Chen, J., Li, X., & Qiu, Z.-K. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00930-9 · Cited by 26
A Review on the General Stability of Mood Disorder Diagnoses Along the Lifetime
Vega, D., Piña, A., Gallego, F. J. P., Kelly, S. A., & Giner, L. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0891-1 · Cited by 25
Zhou, Q., Wu, Z., Wang, Y., Liu, X., Chen, J., Wang, Y., Su, Y., Zhang, C., Peng, D., Hong, W., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13030 · Cited by 20
Boer, S., Dekkers, O. M., le Cessie, S., Carlier, I. V. E., & van Hemert, A. M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.035 · Cited by 13
Rhee, T. G., Mohamed, S., & Rosenheck, R. A. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.081 · Cited by 12
Oh, H., Newton, D. F., Lewis, D. A., & Sibille, E. L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.827972 · Cited by 13
“Remission rates following 14 weeks of SSRI treatment are only 30% (7), and 20–35% of patients develop a chronic illness during a 4-year follow-up (8).”
BackgroundInfluentialBiomarker-Guided Tailored Therapy in Major Depression
Perna, G., Spiti, A., Torti, T., Daccò, S., & Caldirola, D. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4402-2_19 · Cited by 11
Nogami, W., Nakagawa, A., Katayama, N., Kudo, Y., Amano, M., Ihara, S., Kurata, C., Kobayashi, Y., Sasaki, Y., Ishikawa, N., et al. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s384705 · Cited by 8
“Our findings are in line with those of prior studies that reported an association of a lower level of extroversion with poorer treatment outcomes(23) and chronic depression.(24,57) One study showed that social inhibition, including the trait of personal reserve, is associated with treatment-resistant depression.”
ResultZhang, M., Yang, Y., Zhao, Y., Sui, C., Sui, Y., Jiang, Y., Liu, K., Yang, S., Wang, L., Chen, B., et al. (2024) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-24-00018 · Cited by 19
Electroconvulsive therapy for depression
Munkholm, K., Jørgensen, K. J., & Paludan‐Müller, A. S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013843 · Cited by 7
Symptom Overlap Between Depression and Borderline Personality Disorder: A Network Analysis
Kew, B. M., Monk, N. J., Conner, T. S., Frampton, C. M., Mulder, R., Porter, R., Carter, J. D., Jordan, J., McIntosh, V. V. W., & Douglas, K. M. (2025) · Personality and Mental Health · doi:10.1002/pmh.70019 · Cited by 10
Adverse effects of electroconvulsive therapy
Munkholm, K., Jørgensen, K. J., & Paludan‐Müller, A. S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014995 · Cited by 9
Schaich, A., Heikaus, L., Assmann, N., Köhne, S., Jauch‐Chara, K., Hüppe, M., Wells, A., Schweiger, U., Klein, J. P., & Faßbinder, E. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00584 · Cited by 7
“About one third of depressive patients develop chronic depression (DSM-5 “persistent depressive disorder”), with depressive symptoms persisting for 2 years or longer (10, 11).”
BackgroundAnmella, G., Meehan, A., Ashton, M. M., Mohebbi, M., Fico, G., Ng, C. H., Maes, M. H. J., Berk, L., Prisco, M. D., Singh, A., et al. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1098 · Cited by 7
“Predictably, recurrent depressive episodes, in particular those with higher severity of symptoms, are associated with a poorer prognosis, greater residual symptoms, and functional impairment [5].”
BackgroundRamos‐Quiroga, J. A., Mora, F., Arostegui, S., Cardoner, N., Etxeandia-Pradera, J.-I., Gómez-Juanes, R., Gómez‐Revuelta, M., Montes, J. M. G., & Vieta, E. (2025) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2025.100313 · Cited by 4
Extraversion modulates cortisol responses to acute social stress in chronic major depression
Chopra, K. K., Katz, J. L., Quilty, L. C., Matthews, S. G., Ravindran, A. V., & Levitan, R. D. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.02.008 · Cited by 6
Lian, J., Lin, Z., Li, X., Chen, G., & Wu, D. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.057 · Cited by 4
An Editor’s Journey Ends, but the Journal’s Mission Continues
Fava, G. A. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524654 · Cited by 5
Perez, T. M., Glue, P., Adhia, D. B., Smith, M. J., Ridder, D. D., Zeng, J., Dillingham, P. W., & Niazi, I. K. (2021) · Research Square · doi:10.21203/rs.3.rs-173667/v1 · Cited by 3
Diabetes and Mental Health: From Distress to Depression
Heinze, G., Guízar-Sánchez, D., & Bernard-Fuentes, N. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_26 · Cited by 2
Balon, R. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000439224 · Cited by 1
Pan, Y., Wang, J., Gao, J., Li, H., & Chen, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1414648/v1 · Cited by 1
Tarai, S. (2019) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-8567-1.ch010
Place de l’inobservance dans le trouble dépressif et sa résistance : état des lieux
Yrondi, A. (2018) · French Journal of Psychiatry · doi:10.1016/s2590-2415(19)30257-0
López-Montoyo, A. (2020) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · doi:10.6035/14109.2020.261277 · Cited by 2
Clinical staging in depression
de la Fuente-Tomás, L., & García‐Portilla, M. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00026-8
de Souza, I. M. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2021.tde-07012022-122626 · Cited by 1
Depression and epigenetics: Epidemiology, pathophysiology, diagnosis, and assessment
O’Neill, J., Patel, P. A., & Kamath, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823039-8.00019-8
van Eeden, W. A., van Hemert, A. M., Giltay, E. J., Spinhoven, P., de Beurs, E., & Carlier, I. V. E. (2022) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001535 · Cited by 1
Diabetes and Mental Health: From Distress to Depression
Heinze-Martin, G., Guizar, D. P., & Bernard, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_29
Inflammatory signaling of HMGB1 in depressive disorder
Jiang, Q., Li, C., Xu, H., Liu, T., & Wang, Y. (2023) · Stress and Brain · doi:10.26599/sab.2023.9060001
MICRO-RNA AS DIAGNOSTIC MODALITY OF MAJOR DEPRESSIVE DISORDER
Ratu, E. (2024) · Journal of Psychiatry Psychology and Behavioral Research · doi:10.21776/ub.jppbr.2024.005.01.5
Well-Being Therapy for Depression
Romanazzo, S., & Cosci, F. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4402-2_14
Cosker, E. (2021) · theses.fr (ABES) · doi:10.70675/b38758e0zd393z4e74za68ez893e1ec6706c · Cited by 1
Baroud, E., Hayek, S. E., Kahil, K., & Shamseddeen, W. (2026) · Middle East Current Psychiatry · doi:10.1186/s43045-026-00670-x
“Major depression is also a recurrent and enduring disorder, with up to one-third of patients suffering from chronic symptoms [4, 14] which amplifies the impact of parental depression on children.”
Metadata
- Authors
- Boschloo, L., Schoevers, R. A., Beekman, A. T. F., Smit, J. H., van Hemert, A. M., & Penninx, B. W. J. H.
- Affiliations
- University Medical Center Groningen (NL)
- Amsterdam Public Health (NL)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 83
- Issue
- 5
- Pages
- 279-288
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2142507491
- Cited by
- 60
- References
- 52
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 9 · 2021: 10 · 2020: 3 · 2019: 6 · 2018: 10 · 2017: 2 · 2016: 2 · 2015: 5
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- major depressive disorder, chronic depression, course of depression, prognosis, risk factors, childhood trauma, personality traits, neuroticism, extraversion, life events, depression severity, age, treatment goals
- MeSH terms
- Adult, Major Depressive Disorder, Female, Humans, Interview, Psychological, Male, Netherlands, Prognosis, Psychiatric Status Rating Scales, Risk Factors, Disease Progression, Adult Survivors of Child Abuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.